Yes, I say hold on to the Advangen business, It will be a massive revenue generator
but at this low low Market cap, how can we/they avoid one of the big boys taking it.
I watched the "long, stultifying and very boring slide" and kept wanting to buy more (I did get a few a
month ago) but I am so over-weight in this I had to resist. The story is powerful-
évolis ONE has shown a statistically significant 80.2% reduction in hair loss
and demonstrated visible improvement in overall hair quality and volume with no adverse effects.
Very nice for a small Bio-tech to pursue health and healing while having a money printing machine on the side.